News on Hiperion Biotech from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hiperion Biotech news from BioPortfolio.com Wed, 10 Feb 2010 08:04:30 GMT en Exploratory data presented for Active Biotechs ANYARA projecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040127&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040127&THISHREF=http://c.moreover.com/click/here.pl%3fz2538600544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040127&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040127&THISHREF=http://c.moreover.com/click/here.pl%3fz2538600544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039920&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039920&THISHREF=http://c.moreover.com/click/here.pl%3fz2538473534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039920&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039920&THISHREF=http://c.moreover.com/click/here.pl%3fz2538473534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039906&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039906&THISHREF=http://c.moreover.com/click/here.pl%3fz2538462908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039906&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039906&THISHREF=http://c.moreover.com/click/here.pl%3fz2538462908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Exploratory data presented for Active Biotechs ANYARA projecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040145&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040145&THISHREF=http://c.moreover.com/click/here.pl%3fz2538609795%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040145&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040145&THISHREF=http://c.moreover.com/click/here.pl%3fz2538609795%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalifornia Chronicle: BiomedReports: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Japan: Exploratory data presented for Active Biotech's ANYARA projecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040142&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040142&THISHREF=http://c.moreover.com/click/here.pl%3fz2538607929%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040142&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040142&THISHREF=http://c.moreover.com/click/here.pl%3fz2538607929%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Exploratory data presented for Active Biotech's ANYARA projecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040147&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040147&THISHREF=http://c.moreover.com/click/here.pl%3fz2538610626%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040147&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040147&THISHREF=http://c.moreover.com/click/here.pl%3fz2538610626%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketwire via Yahoo!: Exploratory data presented for Active Biotech's ANYARA projecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040129&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040129&THISHREF=http://c.moreover.com/click/here.pl%3fz2538601469%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040129&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040129&THISHREF=http://c.moreover.com/click/here.pl%3fz2538601469%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Exploratory data presented for Active Biotech's ANYARA projecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040119&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040119&THISHREF=http://c.moreover.com/click/here.pl%3fz2538598780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040119&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040119&THISHREF=http://c.moreover.com/click/here.pl%3fz2538598780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ADIENNE Pharma & Biotech-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040065&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040065&THISHREF=http://c.moreover.com/click/here.pl%3fz2538561957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040065&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040065&THISHREF=http://c.moreover.com/click/here.pl%3fz2538561957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033853&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033853&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033853&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033853&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033171&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033171&THISHREF=http://c.moreover.com/click/here.pl%3fz2535047334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033171&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033171&THISHREF=http://c.moreover.com/click/here.pl%3fz2535047334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWeb Newswire: Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033015&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033015&THISHREF=http://c.moreover.com/click/here.pl%3fz2534953777%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033015&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hiperion%20Biotech&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033015&THISHREF=http://c.moreover.com/click/here.pl%3fz2534953777%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWebWire: